Skip to main content
Erschienen in: BMC Neurology 1/2015

Open Access 01.12.2015 | Case report

Diagnosing moyamoya syndrome using ultrasound - a case report

verfasst von: Tobias Braun, Martin Juenemann, Dursun Gündüz, Stefanie Schmetsdorf, Florian Roessler, Astrid Grams, Carolin Gramsch, Christian Tanislav

Erschienen in: BMC Neurology | Ausgabe 1/2015

Abstract

Background

Moyamoya syndrome is a vasculopathy characterised by progressive occlusion of the cerebral arteries resulting in the development of abnormal collateral circulation. To diagnose this syndrome, imaging of the cerebral arteries is required including CT- or MR-angiography and conventional angiography. We present a case of moyamoya disease with typical findings detected in the sonography. The diagnosis was suspected after reviewing the initial ultrasound images of the cerebral arteries with evidence for obliterated intracranial arteries and the detection of an existing collateral circulation network.

Case presentation

A 62 years old male patient presented in the hospital’s emergency department with symptoms indicating a subacute cerebrovascular event. Immediate sonographic studies showed a right-sided pulsatile Doppler-signal in the common and internal carotid arteries, suggestive of distal stenoses. In addition, the transcranial examination indicated obliteration of both middle cerebral arteries. Numerous arterial vessels suggestive of leptomeningeal collateral arteries revealed a strong arterial leptomeningeal flow. At this stage of the diagnostic work-up, the collateral circulation network, characteristic of moyamoya disease, was indicated by sonography. Moyamoya syndrome was verified by conventional angiography. The aetiological work remained empty, so the diagnosis of moyamoya disease was established.

Conclusion

Our case report indicates that sonography can be a useful tool for detecting the vaculopathy in moyamoya syndrome. In case routine procedures, such as the CT- or MR-angiography, with evidence for obliterated intracerebral arteries, ultrasound studies might provide important information regarding an existing collateral network in the scope of a moyamoya syndrome.
Hinweise

Competing interests

All authors report no competing interests.

Authors’ contributions

TB and CT treated the patient. TB and CT wrote the manuscript. DG, SS and MJ conducted the extensive aetiological work up. AG and CG provided and interpreted the imaging findings. All authors were involved in the analysis and interpretation of findings. They proved the manuscript und contributed for important intellectual content. All authors contributed to writing the manuscript and approved the final version.
Abkürzungen
CT
computed tomography
ECG
electrocardiogram
MRI
magnet resonance imaging

Background

A moyamoya syndrome is an occlusive disease of cerebral arteries, mainly found in the circle of Willis. This disease is characterized by an abnormal collateral circulation network at the base of the brain that looks like a “puff of smoke,” or “moyamoya” in Japanese [13]. The clinical presentation includes various neurological manifestations such as strokes, seizures or mental retardation, mainly caused by brain ischemia and cerebral bleeding [1]. While computed tomography and MRI-angiography are valid diagnostic tools, the best procedure for visualizing typical findings in moyamoya syndrome is conventional angiography [4]. In a recent case we found evidence supporting the use of ultrasound screenings as a valid method to identify a vasculopathy in the scope of a moyamoya syndrome prior to the comprehensive testing for full diagnosis. Our observation is of particular interest, as the transcranial Doppler/duplex sonography, established as a procedure to examine the main branches of the brain arteries, might also be suitable to investigate smaller intracranial vessels, as demonstrated in our patient with moyamoya vasculopathy. The wide availability of the method and the low risk for unfavourable procedural outcomes are in this context of high relevance. For the case presentation the patient gave written informed candent.

Case presentation

A 62-year-old male presented to the hospital’s emergency department with right-sided mild hemiataxia and mild hemiparesis. Fourteen days prior to admission, the patient had noticed numbness of the fourth and fifth finger of the right hand, which continued to spread up the entire arm. The medical history included hypertension with a prescription of ramipril 5 mg daily.
Initial physical examination revealed a mild hemiparesis with hemiataxia and choreiform movements of the right leg. His left extremities showed increased reflexes-levels as well as a right-sided positive Babinski sign. Otherwise he was in good medical condition. Blood pressure was 140/90 mmHg.
Initial sonographic studies showed a right-sided pulsatile Doppler-signal in the common and internal carotid arteries, suggestive of distal stenosis. In addition, there was moderate increase in flow velocities in the basilar-artery. In contrast the Doppler-spectrum in the intracranial vessels indicated widespread obliteration. Numerous arterial vessels suggestive of leptomeningeal and lenticulostriate collateral arteries revealed a strong collateral flow (Figs. 1 and 2). These findings were interpreted as evidence of moyamoya-syndrome. MRI-angiography (3 Tesla) also suggested the suspected disorder; both middle cerebral arteries were obliterated (Fig. 3). The diagnosis was eventually verified using conventional angiography, which revealed severe stenoses of the internal carotid arteries in the siphon portion, the obliterated vessels of the circle of Willis and the extended collateral leptomeningeal and lenticulostriate network (Figs. 2 and 4).
Further diagnostic including brain imaging revealed the disease burden caused by the vasculopathy. A hypodense lesion dorsolateral to the left-sided caudate nucleus, measuring 15 × 7mm, was detected in the CT scan. Magnetic resonance imaging (diffusion weighted imaging on MRI) showed bilateral water shed ischemic lesions at various stages of development suggesting a haemodynamic infarction mechanism (Fig. 5). MRI findings also indicated previous old haemorrhage in the left-sided putamen.
A cardiac workup revealed a persistent foramen ovale without any indication for deep venous thrombosis or pulmonary embolism. Holter-ECG provided no evidence for an arrhythmia such as atrial fibrillation. An etiological workup ruled out autoimmune disorders and the cerebrospinal fluid showed no abnormalities. As no cause was found, the patient was diagnosed with moyamoya disease.
The patient was prescribed a medication with aspirin and simvastatin. Due to recurrent symptoms during hospitalization (dysarthria, worsening of hemiparesis) clopidogrel was added to the treatment plan for 3 months. At discharge, the patient only suffered from mild hemiparesis. On subsequent follow-up, the vascular status did not change and clinically the patient recovered entirely. After 3 months, the secondary prevention treatment plan was reduced to aspirin as single therapy.

Discussion

In the current medical practice, as soon as the diagnosis of moyamoya syndrome is suspected, conventional angiography is considered as most suitable for detecting typical findings and confirming the diagnosis [4, 5]. Therefore findings detected in previous examinations are relevant to justify the invasive procedure of conventional angiography. In our presented case, the transcranial ultrasonography gave the first indication of moyamoya syndrome. Arterial vessels were found using Doppler/duplex ultrasound unveiling the arterial collateral network and revealed the obliterated middle cerebral artery. The diagnosis was suspected prior to the detection of specific findings in CT or MRI-angiography.
Moyamoya syndrome is a rare cerebrovascular disorder characterised by progressive occlusion of the internal carotid arteries and their branches [5]. In some cases, it also affects the extra-cranial portions of the internal carotid artery. The so-called bottleneck sign, a narrowing of the internal carotid artery above the bulb, represents a typical vascular finding in moyamoya disease [6]. In our patient this finding was not depicted, indicating, at the stage the vasculopathy was diagnosed, the disorder affected mainly the intracranial portions of the brain arteries. In the course of the disease the vessel occlusion leads to the formation of collateral circulation networks needed to sustain sufficient perfusion of the brain. As a result, patients are predisposed to ischemic and haemorrhagic events. Patients with moyamoya syndrome usually present therefore with stroke due to ischemia or intracranial bleeding, but they also complain of migraine-like headache (due to dilated meningeal and leptomeningeal collaterals) or choreiform movements (due to dilated lenticulostriatal moyamoya vessels in the basal ganglia) [7, 8]. The actual cerebrovascular event in our patient was an ischemic stroke; the brain imaging indicated an old intracranial haemorrhage. Within the stroke workup the sonography of the brain arteries detected in an early diagnostic step the characteristic moyamoya sign, the branches of a collateral network. The indication of moyamoya syndrome was therefore evident far in advance standard procedures for imaging intracranial vessels were performed.
The results of the etiological workup are frequently inconclusive and the cause of the disease remains unclear [1, 812]. Idiopathic moyamoya syndrome is the more common type of the disease and is often referred to as true moyamoya disease. It is most prevalent in Asia, (Incidence in Japan: 0.94 in 100.000) while in the Unites States the incidence is significantly lower (0.094 in 100.000) [1, 1315]. Studies have shown that in Caucasian patients the female sex predominates (ratio of 4.25:1) with a more benign course of the disease [1]. The secondary type, simply called moyamoya syndrome, is associated with other disorders, such as sickle cell diseases, graves’ disease, cranial irradiation and other causes [2, 8]. Our patient’s medical history and an extensive workup did not reveal any suspicious findings. As a result, the diagnosis of moyamoya syndrome without a causative disorder was concluded.
It is important to establish the diagnosis of moyamoya syndrome because it determines the acute and subsequent therapeutic management. When an underlying pathology is proved, therapeutic management is guided by treatment of this disorder. Evidence regarding the efficacy of various treatment modalities for moyamoya syndrome is limited. In case of stable clinical conditions, the conservative management may be the preferable option. Further treatment measures follow the current recommendations in stroke therapy. Platelet aggregation inhibitors and other measures such as blood pressure control might be considered to prevent cerebrovascular events [5, 16]. In case of unstable haemodynamic conditions surgery (bypass surgery) may also be considered. Interventional treatment (angioplasty or stenting) was not proven to be successful in treatment of moyamoya disease; it might be an option only in some selected cases [5]. In our patient we succeed with a conservative management, the patients’ clinical status remains stable with minor deficits irrelevant for coping with daily tasks.

Conclusion

Our case report indicates that extra- and intracranial Doppler/duplex Sonography could be an important tool in the diagnostic algorithm for diagnosing a moyamoya syndrome. Numerous vessels suggestive of leptomeningeal and lenticulostriate collaterals were obvious, guiding the diagnosis of moyamoya syndrome. Additional specific findings such as obliterated middle cerebral arteries in the CT- or MRI-angiography were detected later. Ultrasound studies may be therefore helpful to enforce the suspected diagnosis of a vascular disorder in the scope of moyamoya syndrome. Sonography should be further investigated with larger cohorts in the diagnostic evaluation of moyamoya to determine its diagnostic accuracy.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the corresponding author.

Acknowledgements

We thank Helga Reckhaus, our technical assistant, for the support performing the sonography studies.

Disclosures

All authors report no disclosures related to this manuscript.

Sponsorship/Funding

None.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Competing interests

All authors report no competing interests.

Authors’ contributions

TB and CT treated the patient. TB and CT wrote the manuscript. DG, SS and MJ conducted the extensive aetiological work up. AG and CG provided and interpreted the imaging findings. All authors were involved in the analysis and interpretation of findings. They proved the manuscript und contributed for important intellectual content. All authors contributed to writing the manuscript and approved the final version.
Literatur
1.
Zurück zum Zitat Burke GM, Burke AM, Sherma AK, Hurley MC, Batjer HH, Bendok BR. Moyamoya disease: a summary. Neurosurg Focus. 2009;26:E11.PubMedCrossRef Burke GM, Burke AM, Sherma AK, Hurley MC, Batjer HH, Bendok BR. Moyamoya disease: a summary. Neurosurg Focus. 2009;26:E11.PubMedCrossRef
2.
Zurück zum Zitat Houkin K, Ito M, Sugiyama T, Shichinohe H, Nakayama N, Kazumata K, et al. Review of past research and current concepts on the etiology of moyamoya disease. Neurol Med Chir (Tokyo). 2012;52:267–77.CrossRef Houkin K, Ito M, Sugiyama T, Shichinohe H, Nakayama N, Kazumata K, et al. Review of past research and current concepts on the etiology of moyamoya disease. Neurol Med Chir (Tokyo). 2012;52:267–77.CrossRef
3.
Zurück zum Zitat Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7:1056–66.PubMedCrossRef Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7:1056–66.PubMedCrossRef
5.
Zurück zum Zitat Kronenburg A, Braun KP, van der Zwan A, Klijn CJ. Recent advances in moyamoya disease: pathophysiology and treatment. Curr Neurol Neurosci Rep. 2014;14:423–0423.PubMedCrossRef Kronenburg A, Braun KP, van der Zwan A, Klijn CJ. Recent advances in moyamoya disease: pathophysiology and treatment. Curr Neurol Neurosci Rep. 2014;14:423–0423.PubMedCrossRef
6.
Zurück zum Zitat Yasaka M, Ogata T, Yasumori K, Inoue T, Okada Y. Bottle neck sign of the proximal portion of the internal carotid artery in moyamoya disease. J Ultrasound Med. 2006;25:1547–52.PubMed Yasaka M, Ogata T, Yasumori K, Inoue T, Okada Y. Bottle neck sign of the proximal portion of the internal carotid artery in moyamoya disease. J Ultrasound Med. 2006;25:1547–52.PubMed
7.
Zurück zum Zitat Parmar RC, Bavdekar SB, Muranjan MN, Limaye U. Chorea: an unusual presenting feature in pediatric Moyamoya disease. Indian Pediatr. 2000;37:1005–9.PubMed Parmar RC, Bavdekar SB, Muranjan MN, Limaye U. Chorea: an unusual presenting feature in pediatric Moyamoya disease. Indian Pediatr. 2000;37:1005–9.PubMed
8.
Zurück zum Zitat Thanavaro JL, Nemani N, Price HI. Moyamoya disease: a case of vanishing cerebral vessels. J Am Assoc Nurse Pract. 2013;25:173–9.PubMedCrossRef Thanavaro JL, Nemani N, Price HI. Moyamoya disease: a case of vanishing cerebral vessels. J Am Assoc Nurse Pract. 2013;25:173–9.PubMedCrossRef
9.
Zurück zum Zitat Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet. 1999;64:533–7.PubMedPubMedCentralCrossRef Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet. 1999;64:533–7.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Yamada H, Deguchi K, Tanigawara T, Takenaka K, Nishimura Y, Shinoda J, et al. Clin Neurol Neurosurg. 1997;99:S221–4.PubMedCrossRef Yamada H, Deguchi K, Tanigawara T, Takenaka K, Nishimura Y, Shinoda J, et al. Clin Neurol Neurosurg. 1997;99:S221–4.PubMedCrossRef
11.
Zurück zum Zitat Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, Kuroda S, et al. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke. 2000;31:930–5.PubMedCrossRef Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, Kuroda S, et al. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke. 2000;31:930–5.PubMedCrossRef
12.
Zurück zum Zitat Yoshida Y, Yoshimoto T, Shirane R, Sakurai Y. Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: An extensive follow-Up study. Stroke. 1999;30:2272–6.PubMedCrossRef Yoshida Y, Yoshimoto T, Shirane R, Sakurai Y. Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: An extensive follow-Up study. Stroke. 1999;30:2272–6.PubMedCrossRef
13.
Zurück zum Zitat Battistella PA, Carollo C. Clinical and neuroradiological findings of moyamoya disease in Italy. Clin Neurol Neurosurg. 1997;99 Suppl 2:S54–7.PubMedCrossRef Battistella PA, Carollo C. Clinical and neuroradiological findings of moyamoya disease in Italy. Clin Neurol Neurosurg. 1997;99 Suppl 2:S54–7.PubMedCrossRef
14.
Zurück zum Zitat Hallemeier CL, Rich KM, Grubb Jr RL, Chicoine MR, Moran CJ, Cross III DT, et al. Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke. 2006;37:1490–6.PubMedCrossRef Hallemeier CL, Rich KM, Grubb Jr RL, Chicoine MR, Moran CJ, Cross III DT, et al. Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke. 2006;37:1490–6.PubMedCrossRef
15.
16.
Zurück zum Zitat Tamogami R, Oi S, Nonaka Y, Miwa T, Abe T. Clinical prognosis and therapeutic aspects in management of pediatric moyamoya disease. Nippon Rinsho. 2010;68:45–52.PubMed Tamogami R, Oi S, Nonaka Y, Miwa T, Abe T. Clinical prognosis and therapeutic aspects in management of pediatric moyamoya disease. Nippon Rinsho. 2010;68:45–52.PubMed
Metadaten
Titel
Diagnosing moyamoya syndrome using ultrasound - a case report
verfasst von
Tobias Braun
Martin Juenemann
Dursun Gündüz
Stefanie Schmetsdorf
Florian Roessler
Astrid Grams
Carolin Gramsch
Christian Tanislav
Publikationsdatum
01.12.2015
Verlag
BioMed Central
Erschienen in
BMC Neurology / Ausgabe 1/2015
Elektronische ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-015-0518-7

Weitere Artikel der Ausgabe 1/2015

BMC Neurology 1/2015 Zur Ausgabe

Neu in den Fachgebieten Neurologie und Psychiatrie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.